Algerianolide - Compound Card

Algerianolide

Select a section from the left sidebar

Algerianolide

Structure
Zoomed Structure
  • Family: Plantae - Asteraceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Sesquiterpene Lactone
Canonical Smiles CC(=O)O[C@@H]1CC2C(=C)C(=O)O[C@@H]2[C@@H]2[C@]([C@]1(C)O)(O)[C@@H](Cl)[C@H]1[C@@]2(O1)C
InChI InChI=1S/C17H21ClO7/c1-6-8-5-9(23-7(2)19)16(4,21)17(22)11(10(8)24-14(6)20)15(3)13(25-15)12(17)18/h8-13,21-22H,1,5H2,2-4H3/t8?,9-,10+,11+,12+,13+,15-,16-,17+/m1/s1
InChIKey LJVWEMBASBCCFD-KVKYXKAISA-N
Formula C17H21ClO7
HBA 7
HBD 2
MW 372.8
Rotatable Bonds 1
TPSA 105.59
LogP 0.3
Number Rings 4
Number Aromatic Rings 0
Heavy Atom Count 25
Formal Charge 0
Fraction CSP3 0.76
Exact Mass 372.1
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Achillea ligustica Asteraceae Plantae 282745

Showing of synonyms

  • Boudjerda A, Zater H, et al. (2008). A new guaianolide and other constituents from Achillea ligustica.. Biochemical Systematics and Ecology,2008,36,461-466. [View]
Pubchem: 162817336

No compound-protein relationship available.

Structure

SMILES: C1CCC(C(=C)C(=O)O2)C2C3C1CC(O4)C34

Level: 0

Mol. Weight: 372.8 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.31
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.77
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.4

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.27
Plasma Protein Binding
22.31
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
11.21
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.24
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-0.15
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
5.6
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Toxic
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-0.21
Rat (Acute)
5.0
Rat (Chronic Oral)
1.92
Fathead Minnow
4.0
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Toxic

General Properties

Boiling Point
372.23
Hydration Free Energy
-8.7
Log(D) at pH=7.4
0.03
Log(P)
0.96
Log S
-2.22
Log(Vapor Pressure)
-7.93
Melting Point
153.08
pKa Acid
5.53
pKa Basic
2.89
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Adenylate cyclase type 5 P30803 ADCY5_CANLF Canis lupus familiaris 3 0.7270
Adenylate cyclase type 5 P30803 ADCY5_CANLF Canis lupus familiaris 3 0.7270
Avidin P02701 AVID_CHICK Gallus gallus 2 0.7020
Avidin P02701 AVID_CHICK Gallus gallus 2 0.7020

Download SDF